首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer drug resistance

缩写:CANCER DRUG RESIST

ISSN:N/A

e-ISSN:2578-532X

IF/分区:5.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引472
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Linda T Senbanjo,Hanan AlJohani,Mohammed AlQranei et al. Linda T Senbanjo et al.
Aim: The Cluster of differentiation 44 (CD44) transmembrane protein is cleaved by γ-secretase, the inhibition of which blocks CD44 cleavage. This study aimed to determine the biological consequence of CD44 cleavage and i...
Eiman Mukhtar,Daniel Worroll,Giuseppe Galletti et al. Eiman Mukhtar et al.
Aim: We reviewed the radiographic response of three patients with metastatic castration-resistant prostate cancer treated with CRXL301, a docetaxel nanoparticle. For these three patients, we isolated and analyzed circulat...
Derek A Franklin,Jamaal L James,Margaret L Axelrod et al. Derek A Franklin et al.
Aim: Immunotherapy and immune checkpoint inhibitors (ICI) have changed cancer care for many patients; however, breast cancers have exhibited minimal response to single agent ICI therapy. There is a significant need to ide...
Israa Salem,Nicole M Naranjo,Amrita Singh et al. Israa Salem et al.
Cells are known to release different types of vesicles such as small extracellular vesicles (sEVs) and large extracellular vesicles (LEVs). sEVs and LEVs play important roles in intercellular communication, pre-metastatic niche formation, a...
Simone Anfossi,George A Calin Simone Anfossi
Development of drug resistance represents the major cause of cancer therapy failure, determines disease progression and results in poor prognosis for cancer patients. Different mechanisms are responsible for drug resistance. Intrinsic genet...
Leora M Nusblat,Shaili Tanna,Charles M Roth Leora M Nusblat
Aim: Improved treatment strategies are desperately needed for eradicating cancer stem cells (CSCs), which drive malignancy and recurrence in glioblastoma multiforme. Hypoxic regions within the tumor microenvironment help ...
Terry S Elton,Hatice Gulcin Ozer,Jack C Yalowich Terry S Elton
DNA topoisomerase IIα (170 kDa, TOP2α/170) induces transient DNA double-strand breaks in proliferating cells to resolve DNA topological entanglements during chromosome condensation, replication, and segregation. Therefore, TOP2α/170 is a...
Andrea Bild,Jia-Ling Teo,Michael Kahn Andrea Bild
Cancers are heterogeneous at the cellular level. Cancer stem cells/tumor initiating cells (CSC/TIC) both initiate tumorigenesis and are responsible for therapeutic resistance and disease relapse. Elimination of CSC/TIC should therefore be a...
Reetobrata Basu,John J Kopchick Reetobrata Basu
Pituitary derived and peripherally produced growth hormone (GH) is a crucial mediator of longitudinal growth, organ development, metabolic regulation with tissue specific, sex specific, and age-dependent effects. GH and its cognate receptor...
Charlotte Hill,Yihua Wang Charlotte Hill
Epithelial-mesenchymal transition (EMT) and autophagy are both known to play an important role in the development of cancer. Subsequently, these processes are now being utilised as targets for therapy. Cancer is globally one of the leading ...